Advertisement: TTP
Advertisement: CJBS mid banner
Advertisement: Cambridge Network mid banner
St Johns Innovation Centre
Astrazeneca advertisement
Advertisement: PwC midbanner
Advertisement: Mills and Reeve mid banner
Advertisement: Barclays Corporate
17 April, 2011 - 14:15 By Tony Quested

Horizon named Young Business of the Year

Dan Cowell (centre) and Darrin Disley of Horizon Discovery at the podium after receiving the Young Business of the Year Award from Anglian Water’s Mark Pendlington (left)

Horizon Discovery was named Young Company of the Year – a new category – at the 21st Anniversary Awards.

 

This was a special award which the Judges decided to make to an outstanding young company whose progress in the year was stunning – a whisker away from Business of the Year but ‘One to Watch’ for a string of international Awards and successes in the very near future.

Horizon executive chairman, Dr Darrin Disley was presented with the award by Mark Pendlington of sponsor, Anglian Water.

Horizon Discovery is a global pioneer in personalised medicine. It has more than doubled space and headcount in Cambridge and is recruiting ready for expansion in the US. It has a long queue of internationally renowned admirers, from investors to collaborators.

The Company’s proprietary virally-mediated gene-engineering technology, GENESIS™, enables any endogenous gene in a human cell-line to be altered quickly, reliably and without introducing unwanted and confounding genotypes and/or phenotypes. Using GENESIS, Horizon Discovery has developed X-MAN™ (Gene-X; Mutant And Normal) cell models, which are the world’s first source of genetically-defined and patient-relevant human cell lines.

Founded in 2007 by Dr Chris Torrance and Professor Alberto Bardelli, and with headquarters in Cambridge, the company builds on a long heritage in gene-engineering, cancer research and translational medicine, and draws on intellectual property and know-how from the University of Washington, the Johns Hopkins University, the University of Maryland, the University of Minnesota and the Department of Oncological Sciences at the University of Torino Medical School.

Over 150 scientific papers relating to the use of X-MAN cell line pairs generated using GENESIS have been published.

Picture by Cameo Photography, www.cameostudios.co.uk

Add new comment

Newsletter Subscription

Stay informed of the latest news and features